NasdaqGS:STOKBiotechs
Is Stoke Therapeutics (STOK) Still Attractive After A 346% One Year Share Price Surge
Wondering whether Stoke Therapeutics at around US$33.78 is starting to look expensive or if there is still value on the table? This article walks through the key numbers so you can judge for yourself.
The stock has been volatile, with a 4.8% decline over the last 7 days, an 11.3% gain over 30 days, a 9.3% return year to date, a 345.6% return over 1 year, a 266.0% return over 3 years, and a 34.9% decline over 5 years.
These price swings sit against a backdrop of ongoing attention on Stoke...